Search Results

ABT-751 100 mg  | 98.84%

TargetMol

ABT-751 (E7010) has been investigated for the treatment of Lung Cancer, Non-Small Cell Lung Cancer, and Non-Small-Cell Lung Cancer.

More Information Supplier Page

ABT-751 5 mg  | 98.84%

TargetMol

ABT-751 (E7010) has been investigated for the treatment of Lung Cancer, Non-Small Cell Lung Cancer, and Non-Small-Cell Lung Cancer.

More Information Supplier Page

Lesinurad 100 mg  | Purity Not Available

TargetMol

Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout. Lesinurad has had a limited clinical use but has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.

More Information Supplier Page

Capivasertib 5 mg  | 99.29%

TargetMol

Capivasertib (AZD5363) is a new-type orally available inhibitor of the serine/threonine protein kinase AKT (IC50s: 3/7/7 nM for Akt1/2/3).

More Information Supplier Page

Capivasertib 25 mg  | 99.29%

TargetMol

Capivasertib (AZD5363) is a new-type orally available inhibitor of the serine/threonine protein kinase AKT (IC50s: 3/7/7 nM for Akt1/2/3).

More Information Supplier Page

Capivasertib 100 mg  | 99.29%

TargetMol

Capivasertib (AZD5363) is a new-type orally available inhibitor of the serine/threonine protein kinase AKT (IC50s: 3/7/7 nM for Akt1/2/3).

More Information Supplier Page

BMH-21 10 mg  | 99.47%

TargetMol

BMH-21, a small molecule DNA intercalator, binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription and not affects phosphorylation of H2AX.

More Information Supplier Page

BMH-21 50 mg  | 99.47%

TargetMol

BMH-21, a small molecule DNA intercalator, binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription and not affects phosphorylation of H2AX.

More Information Supplier Page

Raddeanin A 10 mg  | 99.05%

TargetMol

Raddeanin A has moderate inhibitory activity against histone deacetylases (HDACs). Raddeanin A has high antiangiogenic potency, antitumor activity.

More Information Supplier Page

Aloxistatin 10 mg  | 99.47%

TargetMol

Aloxistatin is an inhibitor of cysteine protease with blood platelet aggregation inhibiting activity. Aloxistatin is an irreversible, membrane-permeable inhibitor of lysosomal and cytosolic cysteine proteases with the ability to inhibit calpain activity in intact platelets.

More Information Supplier Page